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Abstract While knowledge about symptom presentation
of adults with mild ASD, including comorbid psychopa-
thology, is limited, referral of adults with suspected mild
PDD is increasing. We report on pilot research investigating
whether patients diagnosed with mild ASD (n = 15) and
patients who were not diagnosed with ASD (n = 21) dif-
fered in terms of (a) AQ scores and (b) Axis I and II dis-
orders, assessed by the SCAN and the IPDE. Additionally,
AQ scores were compared with those from non-ASD pa-
tients referred to a general outpatient clinic (n = 369). The
results showed very few differences between ASD patients
and non-ASD patients. Self-report may not differentiate
mild ASD patients from non-ASD patients and Axis I and II
disorders seem equally prevalent among these two groups.
Keywords Autism Spectrum Quotient  Adult Autism
Spectrum Disorders  PDDNOS  Comorbidity  Personality
disorders
Introduction
Although there is consensus (APA, 1994) about DSM IV
criteria for children and adolescents with Autistic Disorder
and Asperger’s disorder, the largest category, PDDNOS,
remains difﬁcult to classify. The latter is even more true for
adult patients since the DSM-IV criteria are not formulated
with adult age in mind (Gillberg, 1998; Tamtam, 1991;
Vermeulen, 2002). The Autism Diagnostic Interview –
Revised (ADI-R, Lord, Rutter, & Le Couteur, 1994) and
the Autism Diagnostic Observation Schedule-Generic
(ADOS-G; Lord et al., 2000) are validated only for chil-
dren and adolescents. Follow-up studies of adolescents and
adults with autism indicate that a slow decrease in symp-
toms across time occurs in a small group, particularly the
less severely affected patients (Seltzer, Shattuck, Abedutto,
& Greenberg, 2004). However, there is a lack of knowl-
edge about adults with mild ASD, i.e., Asperger’s Disorder
and PDDNOS.
In light of this limited knowledge on symptom presen-
tation in adults, the present paper reports on a pilot re-
search-project that was done with two aims: (a) to test the
Autism Spectrum Quotient (AQ; Baron-Cohen, Wheel-
wright, Skinner, Martin, & Clubley, 2001) as an instrument
for screening adult non-mentally retarded patients for ASD.
We hypothesised that scores would be higher for an ASD
group than for two non-ASD comparison groups; (b) there
is ‘‘a clinical feeling’’ that mild ASD symptoms often mix
with other disorders (e.g., Obsessive Compulsive Disorder
or Schizoid Personality Disorder). Therefore, in patients
referred to an ASD expertise-centre, prevalences of Axis I
and II comorbid disorders were estimated to test the
hypothesis that certain diagnoses are more prevalent
among ASD patients than non-ASD patients.
Method
Participants
Two groups of patients were investigated; the ﬁrst group
(n = 36) consisted of patients referred to the ‘‘Autism
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outpatient center of expertise for the three Northern prov-
inces of the Netherlands (1.5 million inhabitants). On a
yearly basis, about 80 new adult patients are referred for
diagnostic evaluation and (advice for) treatment. Since the
ATN is a ‘‘third line’’ center of expertise, all patients were
referred by psychiatrists and psychologists, working in the
ﬁeld of adult (but not forensic) psychiatry. Only patients
with parents who were able to give the required informa-
tion were included in the present study. They were 18 years
or older, with an estimated IQ higher than 80. Over a span
of 10 months from February 2003 through October 2003,
60 eligible patients were asked to participate, of which 35
patients and their parents consented. The patients were
randomly assigned to two experienced (child) psychiatrists
(CK or EH) for diagnostic assessment.
The second group (n = 369) consisted of patients from
the same region, who were referred in this same period to
the general outpatient psychiatric clinic of the University
Medical Centre Groningen. This group from the general
outpatient clinic (GOC) enabled us to compare the scores
on the AQ screening instrument.
Instruments
The clinical standardized diagnostic protocol that was used
in the intake of ATN-referred patients consisted of a semi-
structured interview (taken from at least one of the par-
ents), and observations from the ADI-R, ADOS-G, as well
as clinical experience. Actual ASD symptoms were trans-
lated in the interview as much as possible to the adult-
world situation. Questions about the past were used to
reconstruct the developmental history of the patient as
adequately as possible. The information derived from the
diagnostic protocol was subsequently used to score the
DSM-IV criteria on ASD. Intelligence was assessed by
using a short version of the ‘‘Groninger Intelligentie Test’’
(GIT, Luteijn, 1966).
For classiﬁcation of PDDNOS, the minimal amount of
positive DSM-IV criteria was two, of which at least one
derived from the social interaction domain. For Asperger’s
Disorder at least two items on the social domain and at
least one item on the stereotypic domain needed to be
present with no early delay of language. For High Func-
tioning Autism at least six items were needed to be present,
with at least two items on the social domain and at least
one positive item on each of the other two domains, with
onset of abnormal functioning before the age of three
years.
The reliability of the diagnostic protocol was tested by
assessing a series of seven patients simultaneously by two
experienced (child) psychiatrists (CK and EH). These
independent classiﬁcations differed only on one patient
(PDDNOS versus non-ASD). The seven patients were not
included in the present study, which started after having
determined diagnostic reliability.
The AQ was translated in Dutch and was named AQ-D
(Dutch). This self-report screening questionnaire has 50
items, which score on 5 domains of behavior: social skill,
attention switching, attention to detail, communication, and
imagination. Each domain has a maximum score of 10 (for
details on this instrument, see Baron-Cohen et al., 2001)
The AQ-D was completed by the patient before the clinical
procedure started. The investigators were blind to the
outcome of AQ-D scores. Internal consistency reliability
estimates (Cronbach’s a) for AQ subscales were acceptable
for the ASD-group but somewhat on the lower side for the
non-ASD groups. Averaged across the ﬁve subscales
Cronbach’s a was .67 for the ASD group, .62 for the non-
ASD group referred to the ATN, and .59 for the GOC
group. For the total scale internal consistency reliability
was acceptable in all three groups: i.e., .85, .82, and .79,
respectively.
Present and life-time comorbidity were assessed by
using the Schedules for Clinical Assessment in Neuro-
psychiatry (SCAN-2.1, Giel & Nienhuis, 1996; World
Health Organisation, 1992) and the International Person-
ality Disorder Examination (IPDE, Loranger et al., 1994).
IQ, SCAN and IPDE assessments were done by a psy-
chologist (JB) who was blind to the outcome of the ASD
psychiatric diagnosis. JB was formally trained by the
Groningen WHO Training Center for administering the
SCAN.
Statistical Analysis
Chi-square tests and analyses of variance were conducted
to analyze possible differences between the groups.
Results
Fifteen of the 36 patients were diagnosed with ASD. In this
ASD-group, 10 patients classiﬁed as PDDNOS, 4 patients
as Asperger’s Disorder and 1 patient as High Functioning
Autism. The number of positive DSM-IV items ranged
from 2 to 8, with an average score of 3.8.
Table 1 shows gender, age, and IQ of ASD and non-
ASD patients. Also included in this table are gender and
age of the GOC patients. The signiﬁcant differences be-
tween the groups were (a) the younger age of the ASD
patients relative to the other patients groups; (b) the
younger age of the non-ASD group referred to the ATN
relative to the GOC patients; and (c) the predominance of
males in the ATN-referred patients compared with the
GOC patients.
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the three groups. Generally, there were no signiﬁcant dif-
ferences between the three groups. The one signiﬁcant
difference was on the sub-domain Communication between
the ASD group and the general outpatient group. Further,
within the ASD group, average AQ-D scores varied with
the severity of ASD: High Functioning Autism: 31 (n = 1);
Asperger’s Disorder: 24 (n = 4), and PDDNOS: 21
(n = 10). In light of the small sample sizes the latter dif-
ferences were not tested for statistical signiﬁcance.
Table 3 reports Axis I diagnoses in ASD and non-ASD
patients as assessed by the SCAN. With one exception,
there were no differences in either Axis I or Axis II diag-
noses between the two groups. This held for both actual
and lifetime (not reported) Axis I diagnoses. The one
exception was that more patients were diagnosed with ac-
tual psychotic disorder NOS in the non-ASD group than in
the ASD group. When we aggregated separate categories
into more broad diagnostic categories, i.e., anxiety disor-
ders, psychotic disorders, and mood disorders, there were
no differences between the two groups in past-month or
lifetime diagnoses either, except for actual psychotic dis-
orders (results not shown).
Table 4 reports Axis II diagnoses as assessed by the
IPDE. ASD and non-ASD patients did not differ on indi-
vidual Axis 2 diagnoses. Also, when we tested whether
ASD and non-ASD groups differed with regard to the total
number of patients with any complete, partial, or either of
these two, Axis 2 disorders (bottom two rows, Table 4), we
found no difference between the two groups.
Discussion
Thus far, publications about screening instruments for adult
ASD use the Autism-Spectrum Quotient (AQ; Baron-Co-
hen et al., 2001) or the Autism Spectrum Disorder in
Adults Screening Questionnaire (ASDASQ; Nylander &
Gillberg, 2001). With the help of the latter instrument,
Nylander & Gillberg (2001) and Chang et al. (2003)
estimated a 1.4 and 0.6 % ASD prevalence in a gen-
eral psychiatry outpatient clinic for adults. The AQ was
investigated by Baron-Cohen in 2001 in Asperger’s
Table 1 Characteristics of participants
Diagnosis ASD (n = 15) No ASD (n = 21) General outpatient clinic
(n = 369)
Male/female
a m = 12, f =3 m = 18, f =3 m = 180, f = 189
Average age
b (range, sd) 22 years (18–24, 5) 27 years (18–55, 9) 35 years (14–73, 11)
Mean IQ (sd) 104 (10) 105 (12)
a Difference between GOC group and non-ASD group (chi-square = 14.2, df = 1, p < 0.0001); difference between GOC group and ASD group
(chi-square = 5.8, df = 1, p < 0.05); no difference between ASD group and non-ASD group
b GOC group differs from non-ASD group (p < 0.01) and from ASD group (p < 0.0001); no difference between ASD group and non-ASD
group
Table 2 Mean scores AQ-D (sd) and ANOVA tests for differences in
mean scores
ASD
(n = 15)
No ASD
(n = 21)
General outpatient
clinic (n = 369)
Social skill 5.0 (2.8) 4.2 (2.6) 4.1 (2.6)
Attention
switching
5.1 (2.6) 5.3 (2.4) 5.3 (2.3)
Attention to
detail
3.5 (2.3) 4.4 (2.2) 4.2 (2.3)
Communication* 4.5 (2.1) 3.5 (2.2) 2.8 (1.8)
Imagination 4.4 (2.4) 4.3 (2.0) 3.5 (1.9)
Total 22.5 (8.4) 21.8 (7.6) 19.9 (7.0)
* Signiﬁcant difference between ASD group and GOC group at
p < 0.01
Table 3 SCAN-derived actual (past month) DSM IV Axis I diag-
noses
ASD
(N = 15)
n (%)
No ASD
(N = 21)
n (%)
No disorder 7 (47) 7 (33)
Mood disorder with psychotic
symptoms
2 (13) –
Mood disorder without psychotic
symptoms
2 (13) 3 (14)
Substance abuse 3 (20) 2 (10)
Sleep disorders 4 (27) 6 (29)
Psychotic disorder NOS – 4 (19)*
Schizophrenia – –
Social Phobia 3 (20) 4 (19)
Panic attacks/Agoraphobia 2 (13) 1 (5)
Other anxiety disorders 1 (7) –
Obsessive compulsive disorders 1 (7) 1 (5)
Other disorders 1 (7) 2 (10)
* Signiﬁcant difference between ASD group and no ASD group at
p < 0.05
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pared with several subgroups in the general population, and
was tested again in 2005 at the national diagnostic clinic
for Asperger’s Disorder (Woodbury-Smith, Robinson,
Wheelwright, & Baron-Cohen, 2005). The AQ differenti-
ated the ASD patients adequately from healthy controls,
and ASD patients from non-ASD patients.
The present study tried to replicate the ﬁndings of
Baron-Cohen. However, our results showed that the AQ-D
did not differentiate between an ASD group (predomi-
nantly PDDNOS) and two non-ASD patient groups. Only
for the communication domain, the ASD patients had
higher scores relative to the general outpatient group. It is
of interest to mention here that this domain was also one of
the two domains that differentiated parents of autistic pa-
tients from healthy controls (Bishop et al., 2004). The most
probable explanation of this discrepant outcome is the fact
that the Dutch patients were less severely affected than the
British patients. The ASD patients but also the non-ASD
patients in the Baron-Cohen papers had higher total mean
scores on the AQ (for ASD: 35.8 and 35.6 and for non-
ASD: 26.2) than our patients (ASD: 22.5, non-ASD and
general outpatients: 21.8 and 19.9). By comparison, Brit-
ish, non-psychiatric, control groups typically have total
scores of around 16–17 (Baron-Cohen et al., 2001). Inter-
estingly, the mean score on the recent Japanese version of
the AQ was 29.4 in ASD patients and 22.2 in non-psy-
chiatric controls (Kurita, Koyoma, & Osada, 2005). The
Japanese authors, like we, reasoned that part of the Japa-
nese patients may have been less severely affected relative
to the British patients. They also argued that it is possible
that autistic related behavior as assessed by the AQ is more
prevalent in the Japanese population than in the British. In
the absence of the actual diagnoses of the non-ASD pa-
tients in both the British and one of the Dutch samples, it
remains difﬁcult to pinpoint why scores between the Brit-
ish and Dutch non-ASD patients (26.2 and 21.8/19.9,
respectively) differ. The absence of differences between
scores of the AQ-D in the present study suggests that there
might be ‘‘ASD-like’’ symptoms, as felt by the patients
themselves, present in the non-ASD patients in the ATN-
referred group and in the patients of the general outpatient
clinic, and revealed by self-report. Indeed, the individuals
in the non-ASD group were referred to the ATN for the
possible presence of an ASD diagnosis, so ASD-like
symptoms must have been voiced by these patients even if
these could not be diagnosed as such on the basis of the
standardized diagnostic protocol. In sum, although there
are still many open questions, for example about differ-
ences in scores cross-culturally, the present data suggest
that self-report questionnaires are not adequate for differ-
entiating less severe ASD patients from other patient
groups. Another study is needed to investigate the merits of
an alternative approach to this problem; i.e., a parents/
caregivers questionnaire as a screening tool for adult ASD.
Our second aim was to look into possible differences in
comorbidity of Axis I and Axis II DSM IV classiﬁcations
in ASD and non-ASD groups. This because of the notion
that mild ASD symptoms often mix with symptoms of
other disorders such as Obsessive Compulsive Disorder or
Schizoid Personality Disorder. There is a scarcity of re-
search on this topic. For example, (comorbid) diagnoses of
the British patients were not reported in the paper of
Woodbury-Smith et al. (2005). For the Dutch, ATN-re-
ferred group, however, we took a systematic approach to
diagnosing DSM IV Axis I and II disorders. The results
indicated that, except for Psychotic Disorder NOS which
was diagnosed in roughly 20% of the non-ASD group and
not in the ASD group, there were no signiﬁcant differences
in the pattern of diagnoses between the ASD and non-ASD
patients. Possibly, the difference in Psychotic Disorder
partly accounts for the referral to the ATN and for the
‘‘ASD-like’’ symptoms in these patients as discussed in the
above paragraph. However, the general picture indicated
by our data is that clinical accounts of a relatively high
prevalence and/or a speciﬁc proﬁle of comorbid disorders
in the ASD group relative to the non-ASD group could not
be conﬁrmed.
There are important limitations to this study, among
which is the small number of patients in the ATN-referred
group. This major drawback precludes any deﬁnite con-
clusions. Of note is further that the ASD patients in this
investigation belonged to the less-severe side of the spec-
trum. This makes it difﬁcult to compare results with the
investigations by Baron-Cohen and collegues. Clinical
experience indicates that ASD patients, compared to
Table 4 IPDE derived Axis II diagnoses by ASD status
ASD (N = 15) No ASD
(N = 21)
Complete
n (%)
Partial
n (%)
Complete
n (%)
Partial
n (%)
Paranoı ¨d – – – 1 (5)
Schizoı ¨d 1 (7) 2 (13) 1 (5) 1 (5)
Schizotypical – 1 (7) – –
Antisocial – 1 (7) – –
Borderline 1 (7) – – 1 (5)
Avoidant 1 (7) 1 (7) 2 (10) –
Obsessive compulsive – – 3 (14) 1 (5)
Personality disorder NOS 1 (7) 2 (13) 3 (14) 1 (5)
Any personality disorder 3 (20) 6 (40) 8 (38) 3 (14)
Any personality disorder
partial or complete
7 (47) 10 (48)
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123non-ASD patients, beneﬁt more from treatment by struc-
turing, long-term repetitive treatment, and adaptations of
the environment. This may hold even more when comorbid
conditions are present. Since the prevalence of patients
with less severe ASD is relatively high compared to the
more severe ASD categories, efﬁcient and valid screening
of this group and charting possible comorbidity is conse-
quently an even more important issue. The present study
provided a modest contribution in improving our knowl-
edge in this direction; clearly, much more research is
needed.
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